AIA Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,728
Closed -$2.62M 323
2023
Q4
$2.62M Buy
4,728
+986
+26% +$463K 0.11% 96
2023
Q3
$1.64M Hold
3,742
0.08% 115
2023
Q2
$1.88M Buy
3,742
+1,636
+78% +$784K 0.09% 107
2023
Q1
$1.05M Sell
2,106
-60
-3% -$28.7K 0.06% 149
2022
Q4
$884K Sell
2,166
-442
-17% -$172K 0.05% 151
2022
Q3
$850K Sell
2,608
-66
-2% -$24.2K 0.06% 140
2022
Q2
$938K Sell
2,674
-198
-7% -$80.7K 0.05% 163
2022
Q1
$1.57M Buy
2,872
+1,320
+85% +$694K 0.07% 126
2021
Q4
$1.02M Buy
1,552
+560
+56% +$352K 0.05% 137
2021
Q3
$617K Buy
992
+206
+26% +$138K 0.03% 158
2021
Q2
$526K Buy
+786
New +$434K 0.04% 144

Other funds holding IDXX

AIA Group's IDXX Position: Q1 2024 in Review

AIA Group sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 4,728 shares — an estimated $2.62M sold.

AIA Group first reported a position in IDXX in Q2 2021 and held it in 11 quarters. The position peaked at $2.62M in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • AIA Group reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • AIA Group sold 4,728 Idexx Laboratories shares in Q1 2024, an estimated $2.62M.
  • AIA Group first reported a position in Idexx Laboratories in Q2 2021 and held it in 11 quarters.
  • AIA Group's Idexx Laboratories position peaked at $2.62M in Q4 2023.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on AIA Group's 13F filing for Q1 2024, filed 6 May 2024.